跳至主要内容
临床试验/NCT04968847
NCT04968847已完成不适用

LOCAL: Prospective Multi-Center LOCALized Directional Insemination Trial for Artificial Insemination

Femasys Inc.36 个研究点 分布在 1 个国家目标入组 314 人开始时间: 2021年7月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Femasys Inc.
入组人数
314
试验地点
36
主要终点
Primary Safety: Occurrence of uterine perforation per cycle

研究概览

简要总结

Brief Summary: The objectives of the trial are to evaluate the safety and effectiveness of the FemaSeed Localized Directional Insemination for artificial insemination, now known as the FemaSeed Intratubal Insemination since FDA Cleared under K231730 in September 2023.

详细描述

314 subjects enrolled (signed inform consent) inclusive of 188 subjects in protocol versions 1-4 and 126 subjects in protocol version 5 (including re-consented subjects).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Female, 19-40 years of age, with no tubal, uterine or ovarian infertility factor (including patent fallopian tubes with no evidence of hydrosalpinx)

排除标准

  • Greater than three prior intrauterine insemination (IUI) cycles
  • Current or recent (within the last 3 months) pelvic infection (cervix, endometrium, or fallopian tubes)
  • Prior history of ectopic pregnancy or tubal surgery

结局指标

主要结局

Primary Safety: Occurrence of uterine perforation per cycle

时间窗: At time of procedure

Occurrence of uterine perforation per cycle: defined as the proportion of cycles with one intrauterine insemination with FemaSeed that result in uterine perforation.

Confirmed pregnancy rate at approximately 3 weeks following FemaSeed procedure.

时间窗: 3 weeks

Confirmed pregnancy rate per cycle: defined as the proportion of cycles with one intrauterine insemination with FemaSeed that result in pregnancy.

Primary Safety: Occurrence of ectopic pregnancy per cycle

时间窗: 7 weeks

Occurrence of ectopic pregnancy per cycle: defined as the proportion of cycles with one intrauterine insemination with FemaSeed that result in a definitively confirmed ectopic pregnancy (based on current accepted clinical standards)

次要结局

未报告次要终点

研究者

发起方
Femasys Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (36)

Loading locations...

相似试验